<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Orthopedics

Comprehensive coverage you can count on.

 

Request a Demo

 

12 of the top 15 orthopedic companies depend on SmartTRAK!

We provide up-to-date intel on industry trends, news, financial data and competitor developments. Our team of analysts are experts in their field - all with previous industry experience. We have our finger on the pulse to bring you the most relevant and accurate data, analysis and intelligence so that you can make better, more informed strategic business decisions.

9 Analysts

8 Modules

697 Companies

5,331 Products

Direct Access

to our analysts when you need it.

Daily Updates

on the latest news, earnings calls, studies, patent filings, new products and more!

Analysis and Insights

featuring quarterly Market Recaps, Interviews, Conferences and more!

Q320 ORTHOBIO MARKET RECAP: During Q320, elective surgeries commenced and revenues neared pre-COVID levels, with some companies rebounding with positive year-over-year growth. Johnson & Johnson’s Medical Device EVP Ashley McEvoy noted that their overall US recovery was at ~95% and ~92% in their top 10 IDNs. Similarly, Wells Fargo estimated US elective procedures were down 5-10% YoY for weeks ending September 25.
Kim_DSC_7193C 400x400
Kim French
SmartTRAK Senior Analyst, OrthoBiologics
Q320 EXTREMITIES MARKET RECAP: The return of elective procedures along with the opening up of the US fanned the flames of growth in the US with the Extremities Market returning to pre-COVID growth levels in Q320. Strength in both the Upper Extremities and Foot & Ankle Market fueled the fire with US Extremities heating up with +6.6% growth.
Lisa Mahan
Lisa Mahan
SmartTRAK Vice President, Orthopedics
Q320 US JOINT FLUID MARKET RECAP: While Q220 is down in history as a disastrous quarter, marred by the dark mark of COVID-19, Q320 is the bright ray of sunshine companies in the US Joint Fluid Replacement market had hoped for. For Q320, HA companies shared upbeat notes about renewed product demand, fueled by an uptick in activity from patients.
Freddy Buntoum
Frederique "Freddy" Buntoum
SmartTRAK Senior Analyst, Regen Med
Q320 TRAUMA MARKET RECAP: In the absence of strict COVID restrictions, the jump ball went to the return of healthy trauma volumes during Q320. Major players cited quarterly growth in line with previous years. Q320 picked up the pace and ended +2.0% globally.
Natasha_DSC_7156c 200x200
Natasha Weeks
SmartTRAK Senior Analyst, Trauma & Extremities Fixation
Q320 SOFT TISSUE FIXATION MARKET RECAP: When an unpredictable COVID-19 roller coaster hit the tracks, companies saw revenue plummet in Q220. Reprieve was in the air though, and at the turn of the quarter going into Q320, what was a dreadful situation, turned more positive.
freddie_butoum_v91
Frederique "Freddy" Buntoum
SmartTRAK Senior Analyst, Regen Med
Q320 SPINE MARKET RECAP: Quarterly results hint at a sustained rebound for the Spine market even as the US faces a surge of COVID cases. WW Spine Hardware revenues were up +2.9% in Q320, with the US at +3.8% as surgeons worked through a backlog of patients postponed due to COVID-19.
Julianne_DSC_7241C 200x200
Julianne Burns
SmartTRAK GM, Spine
Q320 ORTHO COMPUTER ASSISTED SURGERY RECAP: Orthopedic robotics is still in the early stages of adoption with SmartTRAK estimating that <25% of US hospitals have a robot and that fewer than 18% of TKA procedures in the US will have been performed robotically by YE2020.
Elise Wolf
Elise Wolf
SmartTRAK GM, SmartTRAK Computer Assisted Surgery
 

Orthopedics Modules

MODULE DETAILS

Extremities - US

Joint arthroplasty implants for shoulder, elbow, wrist, hand, ankle and foot; and internal and external fixation devices – excluding soft tissue fixation.

  • Upper Extremities – Clavicle through Finger
  • Foot & Ankle – Distal Tibia through Toe

OrthoBio - US

Biological or bio-inductive products used in orthopedic/spine/sports medicine applications – excluding amniotic derived products or cell processing.

  • Bone Replacement
  • Cartilage Replacement
  • Soft Tissue Replacement
    • Soft Tissue Augmentation
    • Knee Ligament Replacement Grafts
  • Meniscus Replacement
  • Joint Fluid Replacement

Spine - US

Spine hardware excluding biologics.

  • Spinal Fusion
    • Cervical Fusion
    • MIS Spinal Procedures
    • Thoracolumbar Fusion
    • Thoracolumbar Interbody
  • Disc Replacement
  • Dynamic Devices
  • Vertebral Compression Fracture (VCF)

All Computer Assisted Surgery - US

Surgical planning systems, navigation systems, robotics, radiation reduction technologies, augmented reality and artificial intelligence.

  • Spine CAS
  • Ortho CAS

Total Joints - US/WW

Hardware for total and partial joint arthroplasty.

  • Hip Replacement
  • Knee Replacement

Trauma - US

Hardware for trauma surgery excluding Upper Extremity and Foot & Ankle (which are covered under Extremities).

  • Plates & Screws
  • IM Nailing
  • External Fixation
  • Cannulated Screws
  • Trauma Other (Dynamic hip screws, cables)

Soft Tissue Fixation - US

Soft tissue fixation implants.

  • Extremity Soft Tissue Fixation
  • Hip Soft Tissue Fixation
  • Knee Soft Tissue Fixation
  • Shoulder Soft Tissue Fixation
  • Meniscus Repair
Region
  • EU Extremities -  Separate country Segments for: France, Germany, Italy, Spain and UK
  • EU Trauma - Separate country Segments for: France, Germany, Italy, Spain and UK

 

Weathering the COVID-19 Storm in Orthobiologics

 

Analysis

SmartTRAK Analysis features curated content by our team of industry experts bringing the most relevant information and insight directly to you. Learn about the latest news, emerging technologies or start-ups to watch, conference happenings and more via articles, videos, and interviews we do. Our analysts keep you up-to-date on the latest market trends and competitive developments in our daily updates, quarterly market recaps and market overviews.

 

Orthopedics Markets

SmartTRAK gives you the most comprehensive coverage of major segments (both hardware and orthobiologics) of the Orthopedic industry. SmartTRAK Market Overviews provide a complete and up-to-date snapshot of what’s driving a market, what’s limiting growth and what new technologies are coming on the scene. From procedure volumes and 5-year forecasts to competitive shares, SmartTRAK Market Overviews contain the latest data and insights on Incidence & prevalence, new treatments and technologies, regulatory and reimbursement.

Download Modules & Segments PDF

 

Company Profiles

SmartTRAK profiles all of the public, private and not-for-profit players participating in a market segment. Succinct and up-to-date, each company profile is consistently formatted so you can make an apples-to-apples comparison of revenues, financings, product portfolios, acquisitions and strategic partnerships. Perfect for competitive analysis or M&A research.

 

Product Profiles

Product Profiles are robust and give an in-depth look into the most current information on a particular product. Each product profile includes a description of the technology, summary of clinical studies, regulatory approvals, sales and more —all with links to the original source.  Product profiles provide all of the information you need to size up a competitive product or learn about a new one.

 

Product Explorer Tool

Product Explorer Tool enables you to quickly drill down on the orthopedic market by segment, indication, regulatory status and more giving you an up-to-date view of the global competitive landscape in seconds.

 

Financial Dashboard Tool

Quickly size a market, gauge market share, compare year-over-year growth and spot trends. Users can sort data by market, segment, sub-segment, on quarterly or annual basis and can easily get the financial data they need.

 

Gap Analysis Tool

Quickly visualize your or your competitor’s product portfolio in seconds! Users can quickly see gaps in their own offering and identify potential candidates for acquisition targets that could potentially strengthen their own portfolio.